CSIMarket Company Name, Ticker, Competitors, else..


Calliditas Therapeutics Ab  (NASDAQ: CALT)
Other Ticker:  
 

Calliditas Therapeutics Ab

CALT's Fundamental analysis



Looking into Calliditas Therapeutics Ab growth rates, revenue grew by 49.74 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 322

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.85 %

Calliditas Therapeutics Ab net loss increased from $-44 millions, to $-50 millions in IV. Quarter 2023,

• More on CALT's Growth


Calliditas Therapeutics Ab
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 15.99 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.61.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on CALT's Valuation
 
 Total Debt (Millions $) 103
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,520,479
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -0.10

Calliditas Therapeutics Ab
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 15.99 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 16.61.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.


• More on CALT's Valuation

•  Market Capitalization (Millions $) 2,147
•  Shares Outstanding (Millions) 54
•  Employees 85
•  Revenues (TTM) (Millions $) 129
•  Net Income (TTM) (Millions $) -50
•  Cash Flow (TTM) (Millions $) 134
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) 103
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,520,479
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -0.10

•  Market Capitalization (Millions $) 2,147
•  Shares Outstanding (Millions) 54
•  Employees 85
•  Revenues (TTM) (Millions $) 129
•  Net Income (TTM) (Millions $) -50
•  Cash Flow (TTM) (Millions $) 134
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 1.36
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.65
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com